1297 related articles for article (PubMed ID: 16034410)
1. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
Yang Q; Graham TE; Mody N; Preitner F; Peroni OD; Zabolotny JM; Kotani K; Quadro L; Kahn BB
Nature; 2005 Jul; 436(7049):356-62. PubMed ID: 16034410
[TBL] [Abstract][Full Text] [Related]
2. Metabolism: A is for adipokine.
Muoio DM; Newgard CB
Nature; 2005 Jul; 436(7049):337-8. PubMed ID: 16034406
[No Abstract] [Full Text] [Related]
3. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.
Graham TE; Yang Q; Blüher M; Hammarstedt A; Ciaraldi TP; Henry RR; Wason CJ; Oberbach A; Jansson PA; Smith U; Kahn BB
N Engl J Med; 2006 Jun; 354(24):2552-63. PubMed ID: 16775236
[TBL] [Abstract][Full Text] [Related]
4. Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes.
Wolf G
Nutr Rev; 2007 May; 65(5):251-6. PubMed ID: 17566551
[TBL] [Abstract][Full Text] [Related]
5. Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in mice.
Tan Y; Sun LQ; Kamal MA; Wang X; Seale JP; Qu X
Biochim Biophys Acta; 2011 Dec; 1811(12):1045-53. PubMed ID: 21983273
[TBL] [Abstract][Full Text] [Related]
6. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle.
Carvalho E; Kotani K; Peroni OD; Kahn BB
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E551-61. PubMed ID: 15928024
[TBL] [Abstract][Full Text] [Related]
7. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.
Yao-Borengasser A; Varma V; Bodles AM; Rasouli N; Phanavanh B; Lee MJ; Starks T; Kern LM; Spencer HJ; Rashidi AA; McGehee RE; Fried SK; Kern PA
J Clin Endocrinol Metab; 2007 Jul; 92(7):2590-7. PubMed ID: 17595259
[TBL] [Abstract][Full Text] [Related]
8. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass.
Klöting N; Graham TE; Berndt J; Kralisch S; Kovacs P; Wason CJ; Fasshauer M; Schön MR; Stumvoll M; Blüher M; Kahn BB
Cell Metab; 2007 Jul; 6(1):79-87. PubMed ID: 17618858
[TBL] [Abstract][Full Text] [Related]
9. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
[TBL] [Abstract][Full Text] [Related]
10. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4.
Kim JK; Zisman A; Fillmore JJ; Peroni OD; Kotani K; Perret P; Zong H; Dong J; Kahn CR; Kahn BB; Shulman GI
J Clin Invest; 2001 Jul; 108(1):153-60. PubMed ID: 11435467
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific alterations of glucose transport and molecular mechanisms of intertissue communication in obesity and type 2 diabetes.
Graham TE; Kahn BB
Horm Metab Res; 2007 Oct; 39(10):717-21. PubMed ID: 17952832
[TBL] [Abstract][Full Text] [Related]
12. Liver-secreted RBP4 does not impair glucose homeostasis in mice.
Fedders R; Muenzner M; Weber P; Sommerfeld M; Knauer M; Kedziora S; Kast N; Heidenreich S; Raila J; Weger S; Henze A; Schupp M
J Biol Chem; 2018 Sep; 293(39):15269-15276. PubMed ID: 30126844
[TBL] [Abstract][Full Text] [Related]
13. Retinol-binding protein 4 (RBP4) as the causative factor and marker of vascular injury related to insulin resistance.
Majerczyk M; Olszanecka-Glinianowicz M; Puzianowska-Kuźnicka M; Chudek J
Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1267-1275. PubMed ID: 28026829
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity.
Vitkova M; Klimcakova E; Kovacikova M; Valle C; Moro C; Polak J; Hanacek J; Capel F; Viguerie N; Richterova B; Bajzova M; Hejnova J; Stich V; Langin D
J Clin Endocrinol Metab; 2007 Jun; 92(6):2330-5. PubMed ID: 17405846
[TBL] [Abstract][Full Text] [Related]
15. Increased retinol-free RBP4 contributes to insulin resistance in gestational diabetes mellitus.
Chen Y; Lv P; Du M; Liang Z; Zhou M; Chen D
Arch Gynecol Obstet; 2017 Jul; 296(1):53-61. PubMed ID: 28528355
[TBL] [Abstract][Full Text] [Related]
16. Retinol-binding protein 4 in human obesity.
Janke J; Engeli S; Boschmann M; Adams F; Böhnke J; Luft FC; Sharma AM; Jordan J
Diabetes; 2006 Oct; 55(10):2805-10. PubMed ID: 17003346
[TBL] [Abstract][Full Text] [Related]
17. Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes.
Jia W; Wu H; Bao Y; Wang C; Lu J; Zhu J; Xiang K
J Clin Endocrinol Metab; 2007 Aug; 92(8):3224-9. PubMed ID: 17550959
[TBL] [Abstract][Full Text] [Related]
18. GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.
Kotani K; Peroni OD; Minokoshi Y; Boss O; Kahn BB
J Clin Invest; 2004 Dec; 114(11):1666-75. PubMed ID: 15578099
[TBL] [Abstract][Full Text] [Related]
19. Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids.
Tan BK; Chen J; Lehnert H; Kennedy R; Randeva HS
J Clin Endocrinol Metab; 2007 Jul; 92(7):2764-72. PubMed ID: 17456573
[TBL] [Abstract][Full Text] [Related]
20. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
